Tech Company Financing Transactions

Inspirna Funding Round

Inspirna closed a $33 million Series B venture capital round on 6/16/2016. Investors included Novo Ventures, Sofinnova Ventures and Alexandria Venture Investments.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Novo Ventures (Lead Investor) (Nilesh Kumar)

Sofinnova Ventures (Lead Investor) (Antoine Papiernik)

Alexandria Venture Investments

Partnership for New York City Fund

Proceeds Purpose
The financing will support clinical development of Rgenix's lead drug candidates, RGX-104 and RGX-202, as well as further development of its therapeutics pipeline.

Company Information

Company Status
Private & Independent
Mailing Address
310 East 67th St. 1-12
New York, NY 10065
Email Address
Inspirna (formerly Rgenix) is developing first-in-class drugs that target key pathways in cancer progression. Using a discovery platform developed by Rgenix founding scientists at Rockefeller University, we have discovered several novel cancer targets that drive tumor growth and cancer progression.
Inspirna LinkedIn Company Profile
Social Media
Inspirna Company Twitter Account
Company News
Inspirna News
Inspirna on Facebook
Inspirna on YouTube

Management Team

Email & Social
Chief Executive Officer
Masoud Tavazoie
  Masoud Tavazoie LinkedIn Profile  Masoud Tavazoie Twitter Account  Masoud Tavazoie News  Masoud Tavazoie on Facebook
Chief Operating Officer
David Darst
  David Darst LinkedIn Profile  David Darst Twitter Account  David Darst News  David Darst on Facebook
Vice President
Stephen Wald
  Stephen Wald LinkedIn Profile  Stephen Wald Twitter Account  Stephen Wald News  Stephen Wald on Facebook
VP - Bus. Development
Foster Gonsalves
  Foster Gonsalves LinkedIn Profile  Foster Gonsalves Twitter Account  Foster Gonsalves News  Foster Gonsalves on Facebook
VP - Finance
Corey Sohmer
  Corey Sohmer LinkedIn Profile  Corey Sohmer Twitter Account  Corey Sohmer News  Corey Sohmer on Facebook
VP - R & D
Isabel Kurth
  Isabel Kurth LinkedIn Profile  Isabel Kurth Twitter Account  Isabel Kurth News  Isabel Kurth on Facebook
VP - Regulatory Affairs
Michael Szarek
  Michael Szarek LinkedIn Profile  Michael Szarek Twitter Account  Michael Szarek News  Michael Szarek on Facebook



Browse more venture capital transactions:

Prev: 6/16/2016: Nexar venture capital transaction
Next: 6/16/2016: MyTaskit venture capital transaction


Share this article


Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary